Amrutanjan Health Care Ltd

Amrutanjan Health Care Dividend

Amrutanjan Health Care recommended a final dividend of ₹2.90 per share for FY 2025-26. The record date will be finalized later following shareholder approval.

Amrutanjan Health Care Q4 FY26 Results: Net Profit ₹16.2 Cr, Up 6.6% YoY

Amrutanjan Health Care Ltd reported revenue from operations of ₹149.8 Cr (+10.6% YoY) and net profit of ₹16.2 Cr (+6.6% YoY) for Q4 FY26.

Key figure

Net profit ₹16.2 Cr · +6.6% YoY

Amrutanjan Health Care Financial Results

Amrutanjan Health Care reported FY26 financial results and recommended a ₹2.90 dividend per share. The board also appointed new independent directors and internal auditors.

Amrutanjan Health Care Board Meeting Date

Amrutanjan Health Care Ltd will hold a Board Meeting on May 8, 2026, to approve audited financial results for the year ended March 31, 2026, and recommend a final dividend for FY2025-26. The trading window remains closed until May 10, 2026.

Amrutanjan Health Care Board Meeting Date

Amrutanjan Health Care Limited has scheduled a Board Meeting for May 08, 2026. The board will consider audited standalone yearly financial results for the period ended March 2026 and a proposal for a final dividend. The trading window is closed from April 01, 2026, until May 10, 2026.

Amrutanjan Health Care Product Launch

Amrutanjan Health Care Limited launched a new range of Personal Care, Wound Care, and Pain Management products. New brands include Comfy and Smoothe' razors, Amrutanjan Plastry medicated plasters, and Ortho Pain Relief + Oil. These launches signify the company's strategic expansion into the fast-growing grooming and wellness segments.

Amrutanjan Health Care Employee Stock Options

Amrutanjan Health Care Limited has approved the rephrasing of the 'Second Phase ESOP 2' within its Employees Stock Option Scheme 2020. This administrative update was approved by the Nomination and Remuneration Committee on April 17, 2026.

Amrutanjan Health Care Other Announcement

Amrutanjan Health Care Limited submitted its quarterly compliance certificate for the period ended March 31, 2026. The filing confirms the dematerialisation, listing, and cancellation of security certificates received from depository participants as per SEBI regulations.